CX-HA and CS

DEVICE2 trials

Sponsors

D&V FARMA srl

Conditions

Dry Eye Disease (DED)

Unknown Phase

Ophthalmic Solution in Diabetic Corneal Alteration

CompletedNCT06573606

D&V FARMA srlDry Eye Disease (DED)

Start: 2021-09-01End: 2022-09-01Updated: 2024-08-29

Cross-linked CMC and Silk Proteins in Eye Disease

CompletedNCT06605365

D&V FARMA srlDry Eye Disease (DED)

Start: 2021-09-01End: 2022-09-01Updated: 2024-09-20

Related Papers

Enhancing Corneal Sensitivity in Diabetic Patients Through an Innovative Ophthalmic Solution: In Vivo and Vitro Results

Journal of Clinical Medicine2025-01-03